Axa’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
PCMI
AIC
WA
MCM
Axa's NPTN Position: Q4 2020 in Review
Axa sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 23,200 shares — an estimated $141K sold.
Axa first reported a position in NPTN in Q3 2015 and held it in 16 quarters. The position peaked at $1.62M in Q3 2018. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.
- Axa reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
- Axa sold 23,200 NEOPHOTONICS CORP shares in Q4 2020, an estimated $141K.
- Axa first reported a position in NEOPHOTONICS CORP in Q3 2015 and held it in 16 quarters.
- Axa's NEOPHOTONICS CORP position peaked at $1.62M in Q3 2018.
- 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.
Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.